OTCMKTS:MAYNFHedgePath Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding HedgePath Pharmaceuticals Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.28 0.00 (0.00 %) (As of 05/27/2020 04:00 PM ET) Add Compare Share Today's Range$0.28Now: $0.28▼$0.3150-Day Range$0.19MA: $0.25▼$0.2952-Week Range$0.12Now: $0.28▼$0.42Volume2,000 shsAverage Volume20,404 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited is based in Salisbury South, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for HedgePath Pharmaceuticals. Previous Next 2.4 Community Rank Outperform VotesHedgePath Pharmaceuticals has received 19 “outperform” votes. (Add your “outperform” vote.)Underperform VotesHedgePath Pharmaceuticals has received 21 “underperform” votes. (Add your “underperform” vote.)Community SentimentHedgePath Pharmaceuticals has received 52.50% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about HedgePath Pharmaceuticals and other stocks. Vote “Outperform” if you believe MAYNF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MAYNF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldHedgePath Pharmaceuticals does not currently pay a dividend.Dividend GrowthHedgePath Pharmaceuticals does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, HedgePath Pharmaceuticals insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MAYNF Previous Symbol CUSIPN/A CIKN/A Webwww.maynepharma.com Phone61 8 8209 2666Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees780 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:MAYNF Rates by TradingView Receive MAYNF News and Ratings via Email Sign-up to receive the latest news and ratings for MAYNF and its competitors with MarketBeat's FREE daily newsletter. HedgePath Pharmaceuticals (OTCMKTS:MAYNF) Frequently Asked Questions How has HedgePath Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)? HedgePath Pharmaceuticals' stock was trading at $0.1962 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MAYNF stock has increased by 43.0% and is now trading at $0.2805. View which stocks have been most impacted by Coronavirus. Has HedgePath Pharmaceuticals been receiving favorable news coverage? News articles about MAYNF stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. HedgePath Pharmaceuticals earned a news sentiment score of 1.6 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutHedgePath Pharmaceuticals. Who are some of HedgePath Pharmaceuticals' key competitors? Some companies that are related to HedgePath Pharmaceuticals include Bayer (BAYN), OTSUKA HOLDINGS/ADR (OTSKY), Roche (RHHVF), Roche (SNYNF), Sanofi (SAN) and SINR PHAR/PAR VTG FPD 0.01 (SPH). View all competitors. Who are HedgePath Pharmaceuticals' key executives? HedgePath Pharmaceuticals' management team includes the following people: Mr. Scott Anthony Richards, MD, CEO & Exec. Director (Age 55)Mr. Nick Freeman BCom, CA, Group CFO & Company Sec.Mr. Stefan J. Cross, Pres of International Operations (Age 46)Dr. Ilana Stancovski, Chief Scientific Officer & Head of European Market Devel.Ms. Lisa Pendlebury, VP of Investor Relations & Communications What is HedgePath Pharmaceuticals' stock symbol? HedgePath Pharmaceuticals trades on the OTCMKTS under the ticker symbol "MAYNF." How do I buy shares of HedgePath Pharmaceuticals? Shares of MAYNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is HedgePath Pharmaceuticals' stock price today? One share of MAYNF stock can currently be purchased for approximately $0.28. What is HedgePath Pharmaceuticals' official website? The official website for HedgePath Pharmaceuticals is www.maynepharma.com. How can I contact HedgePath Pharmaceuticals? The company can be reached via phone at 61 8 8209 2666. This page was last updated on 5/28/2020 by MarketBeat.com Staff
